Britain's Research Circuit

The Politics of British Science. Martin Ince. Wheatsheaf Books, Brighton, Sussex, 1986. 227 pp. £18.95 HB, £8.95 PB. The British government spends about 4.5 billion pounds (about $7 billion) a year on R&D. This is a little more than 2 percent of GNP—not much different in percentage terms than most other advanced industrial countries. The difference, as Martin Ince and others point out, is that more than half of the British expenditure goes to military research; only the United St

Written bySteven Rose
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Apart from the Ministry of Defence, the civil funding agencies are an untidy mix. There are the ministries themselves, from agriculture to transport, and the five research councils. Civil science spending is supposed to be coordinated through advisory committees, but there is virtually no integration between military and civil research.

This funding structure, which worked modestly well in times of relative affluence, is now creaking badly. It is not merely the starvation of funds that has weakened the British research enterprise during the Thatcher years, but the decapitation of its policy-making processes through the abolishing or devaluing of the central advisory groups. The result, as is well-known, has been a catastrophic loss of morale throughout almost the entire scientific field.

Ince, features editor of the weekly magazine The Engineer, treads familiar ground throughout most of this book, threading his way through the interstices of Britain's science-funding institutions. He does not, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies